Skip to main content
¿Necesita servicios de traducción?
Comuníquese con nuestra mesa de ayuda 24/7/365 al 877-635-9545.
The CDC Updated Recommendations Regarding Interval Between Pfizer Vaccine and Booster Dose hero image

The CDC Updated Recommendations Regarding Interval Between Pfizer Vaccine and Booster Dose

On January 4, 2022, the CDC updated recommendations regarding the interval between a primary series of the Pfizer/BioNTech COVID-19 vaccine and a booster dose. The CDC recommended shortening the interval from 6 months to 5 months for those who received the Pfizer/BioNTech COVID-19 vaccine. The booster interval recommendation for people who received the J&J vaccine (2 months) or the Moderna vaccine (6 months), has not changed.  

One day later, the Advisory Committee on Immunization Practices (ACIP) recommended a single Pfizer/BioNTech COVID-19 vaccine booster dose for persons aged 12 – 15 years at least 5 months after primary series under the FDA’s emergency use authorization (EUA). This recommendation follows closely after the FDA announced an expanded EUA for a single booster dose to individuals 12 years of age and older who have completed a primary series with Pfizer/BioNTech COVID-19 vaccine on January 3, 2022. This expands the use of the Pfizer/BioNTech COVID-19 vaccine as a booster which was previously indicated only for individuals 16 years and older.

Visit https://www.cdc.gov/media/releases/2022/s0104-Pfizer-Booster.html for more information.

ProAct Logo ProAct Logo ProAct Logo
mobile image tablet image desktop image